Background Viral bronchiolitis is the leading cause of hospitalization in children during the
first 12 months of life. There is evidence to support the use of noninvasive ventilation in …

Background Different modalities of noninvasive respiratory support have been
recommended for the management of acute bronchiolitis in the pediatric intensive care unit …

Objectives Bronchiolitis is the most common viral lower respiratory tract infection in children
under age 2 for which high-flow nasal cannula (HFNC) is increasingly used. Understanding …

High-flow nasal cannula (HFNC) is frequently used in infants with acute viral bronchiolitis
outside pediatric intensive care units (PICU). A structured questionnaire was sent out to …

Background Bronchiolitis imposes the largest health care burden on non-elective paediatric
hospital admissions worldwide, with up to 15% of cases requiring admission to intensive …

Objective To determine whether the availability of heated humidified high-flow nasal
cannula (HFNC) therapy was associated with a decrease in need for mechanical ventilation …

Bronchiolitis is one of the most frequent reasons for Pediatric Intensive Care Unit (PICU)
admission in children less than 1 year of age. It causes a wide spectrum of clinical scenarios …

Background The objective was to determine whether high-flow nasal cannula (HFNC), a
promising respiratory support in infant bronchiolitis, could reduce the proportion of treatment …

Purpose Nasal continuous positive airway pressure (nCPAP) is currently the gold standard
for respiratory support for moderate to severe acute viral bronchiolitis (AVB). Although …

Aim Using a high‐flow nasal cannula (HFNC) for infant bronchiolitis is increasingly common,
but insufficiently studied. In this retrospective study, we examined the outcomes of HFNC …